Ronen Ben‐Ami

10.9k citations
158 papers · 5.4k indexed · 1 hit paper · h-index 36

Impact in

Papers in

Ronen Ben‐Ami

153 papers receiving 5.2k citations

Hit Papers

Posaconazole versus voriconazole for primary treatment of invasive aspergillosis: a phase 3, randomised, controlled, non-inferiority trial 2021 · 161 citations
161202120262022202450100150

Peers

Ronen Ben‐Ami
Comparison fields: 5 of 136
  • Applied Microbiology and Biotechnology 523
  • Molecular Medicine 1.1k
  • Infectious Diseases 2.8k
  • Endocrinology 405
  • Epidemiology 2.6k
Replace Giovanni Fadda with:
Giovanni Fadda Italy
G. Petrikkos Greece
Josefina Ayats Spain
Katsunori Yanagihara Japan
Julián Torre‐Cisneros Spain
Susan Whittier United States
Jong Hee Shin South Korea
James S. Lewis United States
Camilla Rodrigues India
Mitsuo Kaku Japan
Ronen Ben‐Ami relative to Giovanni Fadda Italy Giovanni Fadda's profile →
Citations per field
00.5×
Giovanni Fadda · 1×
Citations per year

Countries citing papers authored by Ronen Ben‐Ami

Since Specialization
Citations

This map shows the geographic impact of Ronen Ben‐Ami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronen Ben‐Ami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronen Ben‐Ami more than expected).

Fields of papers citing papers by Ronen Ben‐Ami

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ronen Ben‐Ami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronen Ben‐Ami. The network helps show where Ronen Ben‐Ami may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Ronen Ben‐Ami, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ronen Ben‐Ami Line = papers co-authored together Ronen Ben‐Ami links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20251
2 20252
3 20249
4 20242
5 20240
6 20236
7 20233
8 202311
9 202312
10 202018
11 20179
12 20148
13 20144
14 2013191
15 201016
16 200994
17 200952
18
A Murine Model of Myocutaneous Invasive Aspergillosis
20081
19 2006328
20 200215

About Ronen Ben‐Ami

Ronen Ben‐Ami is a scholar working on Applied Microbiology and Biotechnology, Infectious Diseases, Microbiology, Epidemiology and Molecular Medicine, having authored 158 papers that have together received 5.4k indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (63 papers), Fungal Infections and Studies (52 papers), Pneumocystis jirovecii pneumonia detection and treatment (16 papers), Antibiotic Resistance in Bacteria (11 papers), Infectious Diseases and Mycology (11 papers), SARS-CoV-2 and COVID-19 Research (11 papers), Antibiotic Use and Resistance (10 papers) and Nail Diseases and Treatments (9 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (523 citations), Molecular Medicine (1.1k citations), Infectious Diseases (2.8k citations), Endocrinology (405 citations) and Epidemiology (2.6k citations). Ronen Ben‐Ami has collaborated with scholars based in Israel, United States and China. Frequent co-authors include Dimitrios P. Kontoyiannis, Russell E. Lewis, Yehuda Carmeli, Shiri Navon‐Venezia, David A. Schwartz, Mitchell J. Schwaber, Konstantinos Leventakos, Michael Giladi, Keith S. Kaye and Saul Yedgar. Their work appears in journals such as Clinical Infectious Diseases, Mycoses, Clinical Microbiology and Infection, Journal of Fungi and Antimicrobial Agents and Chemotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026